Kinomica logo — A proteomic-data science and diagnostics company specialisin...

Kinomica

A proteomic-data science and diagnostics company specialising in cell signalling.

Founded 2016 United Kingdom Alderley Edge, United Kingdom 24 employees Series A Total: $3.90M Biopharma, Biotechnology

General Information

Company Name Kinomica
Founded Year 2016
Location United Kingdom Alderley Edge, United Kingdom +4
Employees 24
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

Get notified when Kinomica moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kinomica

Kinomica, founded in 2016 and headquartered in the United Kingdom, is a notable player in the biopharma and biotechnology industries. It operates as a precision medicine research and diagnostics company with a strong niche in cell signalling. Known for its interdisciplinary approach, Kinomica leverages a unique phosphoproteomics platform that merges LC–MS/MS with cutting-edge proprietary bioinformatics to offer tailored R&D and diagnostic services.

Most recently, Kinomica secured a £3.90M Series A investment on 14 December 2020. This round attracted the interest and backing of investors like Longwall Ventures, Alderley Park Ventures, Puffin Point, BioCity Group, and the Business Growth Fund. The capital influx is poised to bolster Kinomica's promising platform, positioning the company for further growth in the lucrative precision medicine market.

Taxonomy: Proteomic-data Science, Diagnostics, Cell Signalling, Precision Medicine, Phosphoproteomics, LC-MS/MS, Bioinformatics, KScanTM, Kinase Activity Measurement, Cell Signalling Networks, Oncology, Drug Discovery, Drug Development, Haem Oncology, Interdisciplinary Research

Services & Products

KScan® Diagnostic Platform
Precision Medicine Solutions
Cancer Treatment Guidance

Target Customers

Clinicians Oncologists Biomedical Researchers Pharmaceutical Companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor
•••• ••••
14 Dec 2020
Venture Round •••••• 1 •••• •••• 29 Aug 2019

Kinomica Alternatives & Competitors

View All Alternatives
Kinomica vs

Every Patient Has the Right to Be Treated

3 employees
Health Care
Kinomica vs
Cumulus Oncology
Cumulus Oncology United Kingdom

Finding assets, creating spin-outs, commercialising cancer therapies.

16 employees
Kinomica vs
AQEMIA
AQEMIA France

Scale drug discovery with quantum-inspired physics and generative AI

Unknown
84 employees
AI, Biotechnology

FAQ About Kinomica

A proteomic-data science and diagnostics company specialising in cell signalling.
Kinomica was founded in 2016.
Kinomica is headquartered in Alderley Edge, United Kingdom.
Kinomica operates in the following industries: Biopharma, Biotechnology.
Kinomica has approximately 24 employees.
Kinomica has completed 2 funding rounds, raising a total of $3.90M. The latest funding stage is Series A.
Kinomica offers: KScan® Diagnostic Platform, Precision Medicine Solutions, Cancer Treatment Guidance.
Top alternatives and competitors to Kinomica include Topmunnity Therapeutics Limited, Cumulus Oncology, AQEMIA, BioArdis, Oncoheroes Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kinomica and Topmunnity Therapeutics Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kinomica and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes